Status:
ACTIVE_NOT_RECRUITING
Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients
Lead Sponsor:
Careggi Hospital
Collaborating Sponsors:
University of Florence
Conditions:
Critical Illness
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The use of extracorporeal blood purification therapies (EBPT) is becoming increasingly widespread worldwide in everyday clinical practice, particularly in the critical care setting. Nonetheless, most ...
Detailed Description
The use of extracorporeal blood purification therapies (EBPT) is becoming increasingly widespread worldwide in everyday clinical practice, particularly in the critical care setting. For most of these ...
Eligibility Criteria
Inclusion
- critically ill patients in the ICU
- treatment with oXiris
Exclusion
- age \< 18 years
Key Trial Info
Start Date :
June 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT03807414
Start Date
June 28 2019
End Date
September 30 2025
Last Update
February 12 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Presidio Ospedaliero di Esine
Esine, Brescia, Italy, 25040
2
S. Giuseppe Hospital
Empoli, Firenze, Italy, 50053
3
IRCCS Policlinico S. Donato Milanese
San Donato Milanese, Milano, Italy, 20097
4
Ospedale Sacro Cuore di Gesù-Fatebenefratelli
Benevento, Italy, 82100